Development and validation of a qualitative GC-MS method for THCCOOH in urine using injection-port derivatization
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cannabis is one of the most abused drugs in Korea. The main psychoactive component in cannabis, Δ9-tetrahydrocannabinol, is metabolized to 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) and THCCOOHglucuronide (THCCOOH-glu) in the human liver, whereby the amount of THCCOOH-glu found in urine is twice as high as that of THCCOOH. The analytical process adapted by the majority of urine drug-testing programs involves a two-step method consisting of an initial immunoassay-based screening test followed by a confirmatory test if the screening test result is positive. In this study, a qualitative gas chromatography-mass spectrometry (GC-MS) method was developed and validated for the detection of THCCOOH in human urine, where THCCOOH-glu was converted into THCCOOH by alkaline hydrolysis. For purification of the urine extract prior to instrumental analysis, high-speed centrifugation was used to minimize interference. In addition, an injection-port derivatization method using ethyl acetate and N,O-bis(trimethylsilyl)-trifluoroacetamide containing 1 % trimethylchlorosilane was employed to reduce the time required for derivatization, and an aliquot of the final solution was injected into the GC-MS. The method was validated by measuring the selectivity, limit of detection (LOD), and repeatability. The sensitivity, specificity, precision, accuracy, Kappa, F-measure, false positive, and false negative rate were determined by comparing the GC-MS results with those obtained using the immunoassay. The LOD was determined to be 0.32 ng/mL, while the repeatability was within 9.1 % for THCCOOH. Furthermore, a comparison study was carried out, whereby the screening immunoassay exhibited a sensitivity of 86.4 % and a specificity of 100 % compared to GC-MS. The applicability of the developed method was examined by analyzing spiked urine and forensic urine samples obtained from suspected cannabis abusers (n = 221).
Abstract
Cannabis is one of the most abused drugs in Korea. The main psychoactive component in cannabis, Δ9-tetrahydrocannabinol, is metabolized to 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH) and THCCOOHglucuronide (THCCOOH-glu) in the human liver, whereby the amount of THCCOOH-glu found in urine is twice as high as that of THCCOOH. The analytical process adapted by the majority of urine drug-testing programs involves a two-step method consisting of an initial immunoassay-based screening test followed by a confirmatory test if the screening test result is positive. In this study, a qualitative gas chromatography-mass spectrometry (GC-MS) method was developed and validated for the detection of THCCOOH in human urine, where THCCOOH-glu was converted into THCCOOH by alkaline hydrolysis. For purification of the urine extract prior to instrumental analysis, high-speed centrifugation was used to minimize interference. In addition, an injection-port derivatization method using ethyl acetate and N,O-bis(trimethylsilyl)-trifluoroacetamide containing 1 % trimethylchlorosilane was employed to reduce the time required for derivatization, and an aliquot of the final solution was injected into the GC-MS. The method was validated by measuring the selectivity, limit of detection (LOD), and repeatability. The sensitivity, specificity, precision, accuracy, Kappa, F-measure, false positive, and false negative rate were determined by comparing the GC-MS results with those obtained using the immunoassay. The LOD was determined to be 0.32 ng/mL, while the repeatability was within 9.1 % for THCCOOH. Furthermore, a comparison study was carried out, whereby the screening immunoassay exhibited a sensitivity of 86.4 % and a specificity of 100 % compared to GC-MS. The applicability of the developed method was examined by analyzing spiked urine and forensic urine samples obtained from suspected cannabis abusers (n = 221).
참고문헌 (29)
- 허경미, "미국의 대마초 합법화 과정 및 주요 쟁점 연구", 한국경찰연구, 17(2), pp.291~316 (2018), 한국경찰연구학회[DOI]
- Korea Customs Service, "Announcement of Drug Smuggling Trends and Countermeasures in 2018", ~ (2019)
- Supreme Prosecutors’ Office, "White paper on drugrelated crimes 2019-Chapter 2", ~ (2020)
- S. Foley, , Rev. Financ. Stud, 32, pp.1798~1853 (2019)
- M. Hädener, , Bioanalysis, 9, pp.485~496 (2017)
- P. M. Kemp, , J. Anal. Toxicol, 19, pp.292~298 (1995)
- M. M. Bergamaschi, , Anal. Bioanal. Chem, 405, pp.4679~4689 (2013)
- O. Aizpurua-Olaizola, , Drug Test. Anal, 9, pp.626~633 (2017)
- W. Kwon, , Anal. Methods, 5, pp.3028~3034 (2013)
- G. M. Reisfield, , Bioanalysis, 1, pp.937~952 (2009)
- A. Saitman, , J. Anal. Toxicol, 38, pp.387~396 (2014)
- A. D. de Jager, , J. Chromatogr. B, 879, pp.2642~2652 (2011)
- S. J. Mulé, , J. Anal. Toxicol, 12, pp.102~107 (1988)
- D. K. Lee, , Food Chem, 141, pp.3931~3937 (2013)
- J. M. Halket, , J. Exp. Bot, 56, pp.219~243 (2005)
- Q. Wang, , J. Chromatogr. A, 1296, pp.25~35 (2013)
- J. Wu, , Anal. Chem, 78, pp.7292~7301 (2006)
- A. Marsol-Vall, , Food Chem, 204, pp.210~217 (2016)
- A. Marsol-Vall, , J. Chromatogr. A, 1453, pp.99~104 (2016)
- A. F. Oliveira, , J. Pharm. Biomed. Anal, 73, pp.53~58 (2013)
- K. F. da Cunha, , Forensic Toxicol, 39, pp.222~229 (2021)
- R. Fogerson, , J. Anal. Toxicol, 21, pp.451~458 (1997)
- P. S. Cheng, , J. Chromatogr. B, 852, pp.443~449 (2007)
- M. Gaugain-Juhel, , Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess, 26, pp.1459~1471 (2009)
- S. P. Elliott, , Sci. Justice, 58, pp.335~345 (2018)
- M. A. ElSohly, "Marijuana and the cannabinoids, Chapter" (2007), Humana Press
- A. J. Barnes, , J. Anal. Toxicol, 27, pp.402~407 (2003)
- 정재철, "고체상 추출과 GC", MS를 이용한 소변 중 대마대사체(THCCOOH) 분석, 2006, pp.19(5), 441~448[DOI]
- J. M. Halket, , Eur. J. Mass Spectrom, 9, pp.1~21 (2003)
